Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Home Care Pionee | Aveanna Healthcare navigates the evolving home care landscape, leveraging strategic initiatives to capitalize on growing demand and market opportunities |
Financial Resilience | Explore Aveanna's impressive Q1 2024 performance, exceeding expectations and prompting an upward revision of full-year guidance |
Strategic Growth Drivers | Delve into Aveanna's multi-pronged strategy, including state legislative initiatives and preferred payor partnerships, aimed at securing market leadership |
Market Valuation Surge | Analyst price targets range from $3.00 to $5.00, reflecting growing investor confidence in Aveanna's strategy and execution in the competitive home care secto |
Metrics to compare | AVAH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVAHPeersSector | |
---|---|---|---|---|
P/E Ratio | −17.2x | 7.9x | −0.7x | |
PEG Ratio | −0.21 | −0.08 | 0.00 | |
Price/Book | −7.3x | 4.1x | 2.6x | |
Price / LTM Sales | 0.6x | 1.4x | 3.2x | |
Upside (Analyst Target) | −1.0% | 58.9% | 44.5% | |
Fair Value Upside | Unlock | 3.1% | 6.6% | Unlock |